PRESS RELEASE

Tuesday February 15

Company Press Release

SOURCE: BioMedicines, Inc.

BioMedicines, Inc. Names Curtis L. Scribner Chief Regulatory Officer

ALAMEDA, Calif., Feb15 --BioMedicines, Inc. today announced that it has named Curtis L. Scribner, M.D., M.B.A. as Chief Regulatory Officer and Vice President Regulatory Affairs.

Dr. Scribner is a native of Nebraska and received his medical training at the University of Colorado and the National Institutes of Health. He is a rheumatologist and immunologist with extensive experience in governmental and scientific affairs. He has also been a field scientist and principal investigator for clinical programs conducted in Africa. Dr. Scribner was a senior physician within the FDA, including duty as a Deputy Director in the Center for Biologic Evaluation and Research where he was responsible for activities within three FDA divisions. More recently he served as Chief Regulatory Scientist for Quintiles Consulting. Dr. Scribner also serves as a member of several scientific and ethical advisory boards for civic and private entities.

"We are very pleased to welcome Dr. Scribner to BioMedicines," said Dr. Mark Moran, Chief Executive Officer of BioMedicines. "Because the company is now entering late stage clinical testing in both Europe and the United States, Dr. Scribner's expertise as a regulatory strategist will be very important to the success of these programs. His further experience as a business person will benefit company licensing efforts as well."

Dr. Scribner said, "I am delighted to join the management team of BioMedicines and foresee a very active year of negotiations and regulatory submissions on behalf of the company."

BioMedicines, Inc., a privately held pharmaceutical company, is developing first line therapies for the treatment of cancer and infectious diseases. The company specializes in redirecting the development of drugs to new and more valuable indications. The company has current development and/or commercialization agreements with Boehringer Ingelheim, Schering AG, and Searle. BioMedicines is headquartered in Alameda, California. More information about the company is available at www.biomedicinesinc.com.

| Back |